Strategic Partnerships Xcellbio has recent and ongoing partnerships with Thermo Fisher Scientific, Royal Perth Hospital, and AmplifyBio, signaling a strong channel for co-developed manufacturing workflows and potential integration opportunities for cGMP cell therapy platforms and automated TIL workflows.

Automation Focus The AVATAR platform and AVATAR Foundry system are central to Xcellbio’s strategy for automated TIL manufacturing, presenting a clear sales angle for automation software, scalable manufacturing hardware, and high-throughput cell processing capabilities.

Clinical Scale Enablement With a mission to translate insights to patient scale and a cGMP cell therapy manufacturing platform, there are opportunities to upsell integrated software, analytics, and workflow solutions that streamline regulatory-compliant production and quality control for cell and gene therapies.

Geographic Footprint Headquartered in Melbourne and San Francisco, the company maintains a global presence that can be leveraged to target biopharma and academic partners across North America and Australia for joint development programs and regional service support.

Financial Health & Growth Revenue in the mid-range of tens of millions and a solid funding base provide a foothold for expanding customer success, after-sales services, and training offerings, as well as pursuing larger multi-year contracts with larger biotech and contract development organizations.